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Abstract
Objective: Automated surveillance of healthcare-associated infections can improve efficiency and reliability of surveillance.
The aim was to validate and update a previously developed multivariable prediction model for the detection of drain-
related meningitis (DRM).
Design: Retrospective cohort study using traditional surveillance by infection control professionals as reference standard.
Patients: Patients receiving an external cerebrospinal fluid drain, either ventricular (EVD) or lumbar (ELD) in a tertiary
medical care center. Children, patients with simultaneous drains, ,1 day of follow-up or pre-existing meningitis were
excluded leaving 105 patients in validation set (2010–2011) and 653 in updating set (2004–2011).
Methods: For validation, the original model was applied. Discrimination, classification and calibration were assessed. For
updating, data from all available years was used to optimally re-estimate coefficients and determine whether extension with
new predictors is necessary. The updated model was validated and adjusted for optimism (overfitting) using bootstrapping
techniques.
Results: In model validation, the rate of DRM was 17.4/1000 days at risk. All cases were detected by the model. The area
under the ROC curve was 0.951. The positive predictive value was 58.8% (95% CI 40.7–75.4) and calibration was good. The
revised model also includes Gram stain results. Area under the ROC curve after correction for optimism was 0.963 (95% CI
0.953– 0.974). Group-level prediction was adequate.
Conclusions: The previously developed multivariable prediction model maintains discriminatory power and calibration in an
independent patient population. The updated model incorporates all available data and performs well, also after elaborate
adjustment for optimism.
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Introduction
Surveillance and feedback of healthcare-associated infection
(HAI) rates to healthcare workers is considered a cornerstone of
infection prevention programs [1,2]. Policy makers and the public
increasingly demand transparent reporting of infection rates to
quantify quality of healthcare, for example through surveillance
networks such as the National Healthcare Safety Network (NHSN)
in the United States or the PREZIES network in the Netherlands
[3–6]. Because of the potential impact of HAI rates on healthcare
utilization and reimbursement, the development of efficient and
reliable surveillance methods is of increasing importance. In many
circumstances, manual chart review of all patients is still the only
available method for surveillance, although it is prone to error due
to effort dependent case-finding and the possibility of inconsistent
interpretation of case definitions [7,8]. Possibilities for automated
surveillance of HAI using a variety of data sources have been
investigated over the past two decades with varying success [9].
A HAI for which routine surveillance is implemented in our
institution is drain-related meningitis (DRM), a relatively frequent
complication of the use of external ventricular (EVD) and lumbar
(ELD) cerebrospinal fluid drains in neurosurgical patients. DRM
rates range from 2 up to 25% per drain placed [10–12] or 7.5 to
32 infections per 1000 days at risk (DAR) [13–15]. Causative
micro-organisms are often skin flora, such as coagulase-negative
staphylococci and Staphylococcus aureus, although in some settings
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Gram-negative micro-organisms (eg enterobacteriaceae) play an
important role [11,13]. Infection rates also depend on the
definition applied. Since surveillance aims to generate insight into
rates and characteristics of DRM, definitions are not necessarily
identical to a clinical diagnosis entailing treatment consequences.
Importantly, some case-definitions, including the CDC-definition
for healthcare-associated meningitis, allow for diagnosis of an
infection without the presence of bacterial growth from clinical
cultures [16,17].
Recently, an accurate prediction model for the automated
surveillance of DRM has been proposed which combines
predictors from multiple sources to identify those patients which
have a high probability of having developed DRM during their
admission, both cases of DRM with and without documented
pathogens in microbiological cultures (Figure 1) [14]. Such a
model can provide more timely and reliable rates of DRM and
manual chart review can then be limited to high-risk patients (with
a high predicted probability of DRM) while maintaining sensitivity
of detection. Importantly, the predictors are all collected during
routine clinical care which facilitates applicability of the model in
practice [18].
Prediction models require validation in independent patient
populations to assess their validity and performance in future use
[19,20]. This research presents the temporal validation of the
DRM prediction model. Besides validation, optimal model
performance in future patients can be achieved by updating the
model using both derivation and validation data [21,22]. Several
newly available predictors were also considered in model updating.
Methods
Ethics statement
As described previously, use of anonymized data from the
clinical data warehouse has been exempted from review by the
institutional review board of our institution [23].
Development study details
For details on model development, please refer to [14]. In brief,
logistic regression was used to develop a prediction model aimed at
identifying patients that developed DRM after placement of an
EVD or ELD. The study was conducted at University Medical
Center Utrecht, a 1042-bed tertiary medical center. Patients who
entered the routine surveillance performed by the department of
hospital hygiene and infection control between January 1st 2004
and December 31st 2009 were included, with the exception of
children, patients with less than one day of follow-up, patients with
known meningitis at the time of placement of the first drain,
patients admitted with a drain in situ or multiple simultaneous
drains, military personnel and multiple (independent) admissions
within the study period (n= 537 in analysis). All EVDs were placed
in operating theatres and are tunneled five centimeters under the
skin. Drains were not coated with antibiotics and all patients
received perioperative antibiotic prophylaxis. ELDs were either
inserted in the operating theatres or in sterile conditions on the
neurology ward. Drains were not exchanged on a prophylactic
basis and CSF samples were collected for culture and biochemical
analysis only when infection was clinically suspected. Clinical care
data were obtained from the Utrecht Patient Oriented Database
(UPOD), a clinical data warehouse developed for research
purposes which links patient characteristics to results from clinical
chemistry and medical microbiology laboratories and pharmacy
records [23]. Missing data were imputed using multiple imputa-
tion, and internal validation was performed [24,25].
Outcome
As in model development, the outcome or reference standard
was the development of DRM, which is defined as the occurrence
of meningitis when the drain is in situ or within seven days of drain
removal. Meningitis is defined according to the CDC-definition
for healthcare-associated meningitis as applied by the department
of hospital hygiene and infection control during routine manual
surveillance. Presence of healthcare-associated meningitis requires
either a positive culture or a combination of clinical signs,
cerebrospinal fluid (CSF) analysis indicative of meningitis and
initiation of empiric antimicrobial therapy by the physician.
Importantly, this definition for meningitis allows for classification
as a meningitis without bacterial growth from microbiological
cultures and requires that cultures with skin flora are evaluated for
possible contamination (Figure 2) [14–16,26]. All charts were
manually reviewed, and possible cases of infection were reviewed
by at least two infection control professionals. In case of
disagreement, consensus was reached through discussion.
Model validation and patient population
The previously developed model for the prediction of DRM was
validated on an independent cohort of consecutive patients that
received an EVD or ELD, selected from the same center though
from a later time period (January 2010 to June 11th 2011), a so-
called temporal validation [19,20]. In this time period, surveillance
for ELDs was limited to drains placed in operating theatres in
2010 and discontinued in 2011. Data on device utilization is
currently collected manually using electronic operating theatre
and ICU records. Children (n = 13), patients with a meningitis at
drain placement (11), patients who died within 24 hours (5) or who
received multiple simultaneous drains (2) and those who were
admitted with a drain already in situ (1) were excluded from the
analysis, leaving 105 patients in the validation set. Approximately
three-quarters of the EVD patients (75 of 99 patients) received a
drain due to hydrocephalus after intracranial hemorrhage; nine
percent received an EVD to treat increased intracranial pressure
caused by a tumor. Five out of six ELD’s were placed as a per-
operative preventive measure. For each patient in the validation
set, the reference standard was determined and predictor data was
collected.
Predictors
Predictors were defined, collected and interpreted as in model
development [14]. Predictors were selected for their ability to
predict the development of DRM, irrespective of a causal
association. Patient characteristics, administrative data (e.g. length
of stay, ICU admissions) and the clinical parameters used in the
Figure 1. Previously derived prediction rule for drain-related
meningitis. For each individual patient, the model returns a predicted
probability of DRM which can be used to classify patients. Abbrevia-
tions: P(DRM) – probability of drain-related meningitis, LP – linear
predictor, EVD – external ventricular drain, CRP – C-reactive protein, CSF
– cerebrospinal fluid.
doi:10.1371/journal.pone.0051509.g001
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prediction model (Figure 1) were extracted from the clinical data
warehouse. Besides the predictors obtained during model devel-
opment, Gram stain results, the location to which the patient was
discharged (i.e. deceased, home or other care facility) and urgency
of admission as recorded in administrative files were also available.
For each patient, all results obtained throughout the surveillance
episode (duration of drainage plus seven days or up to discharge)
were retrieved. For each predictor, the value most indicative of
infection was used as parameter value; for example, for the
peripheral blood leukocyte count the highest value measured
during the surveillance episode was entered in the prediction rule.
Statistical analyses
Missing data were imputed using multiple imputation (10
iterations) to prevent bias that would have occurred if the analysis
had been limited to complete cases only [24]. In Table S1, a
comparison of cases with and without missing data is given. For
model validation, imputation was performed on the validation set
only. A new imputation was run on the development and
validation set combined for model update (see below). The
original model depicted in Figure 1 was validated. Discrimination,
classification and prediction at the group level (calibration-in-the-
large) were assessed.
Model updating
Since datasets from both model development and validation
were available, we investigated whether the original model could
be improved or updated using both datasets combined and hence
make maximal use of all data [21,27]. As opposed to model
derivation, patients with multiple simultaneous drains were no
longer excluded since they are not expected to be different in terms
of diagnosis of DRM. Furthermore, during the updating process,
one misclassification error in the model development data was
resolved and all data were adapted accordingly thus slightly
improving performance characteristics obtained in the model
development. All predictors from the original model were included
in the revised model to re-estimate their coefficients. In addition,
the new predictors (Gram stain, urgency of admission and
discharge destination) were added to the model if they significantly
improved the model (likelihood ratio test, p-value of 0.05). Gram
stain results were combined with CSF culture result and CRP was
included as a fractional polynomial to accommodate the non-
linear association between CRP and risk of DRM [28]. Estimates
were derived from the 10 imputation sets and pooled using
Rubin’s rule, a method that takes into account variation within
and between multiple imputation data sets [25].
Then, internal validation was performed by bootstrapping (100
samples per imputation set, including predictor selection using all
predictors considered in model development and update) and a
uniform shrinkage factor was applied, this to prevent over-
optimism and to make the model generalizable to future patient
populations [29]. The final model is presented along with its
optimism-corrected performance characteristics. Analyses were
performed with SPSSH version 19 (SPSS Inc, Chicago IL) and R
version 2.14.1 (www.r-project.org).
Results
Model validation
Model validation was performed on 105 patients who received
134 drains. Nearly all patients in the surveillance received an EVD
(94.3%), due to discontinuation of ELD surveillance. The infection
rate in the validation period was 17.3 per 1000 drainage days at
risk (DAR). All infections occurred in patients receiving an EVD.
In fifty percent of infections, no positive culture was obtained.
Figure 2. Modified CDC-definition for healthcare-associated meningitis (reference standard).
doi:10.1371/journal.pone.0051509.g002
Table 1. Contingency table with results of model validation
with 95% confidence intervals for sensitivity, specificity and
predictive values.
Predicted
probability DRM (%) 95% CI
Yes No Total Sensitivity 100.0 (83.2–100)
P(DRM) .0.107 20 14 34 Specificity 83.5 (73.9–90.7)
P(DRM) #0.107 0 71 71 PPV 58.8 (40.7–75.4)
Total 20 85 105 NPV 100.0 (94.9–100)
Abbreviations: NPV – negative predictive value, PPV – positive predictive value,
P(DRM) – predicted probability of drain-related meningitis.
doi:10.1371/journal.pone.0051509.t001
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Median age in the validation set was 59.3 years (model
development 58.5 years), 65.7% of patients were female (model
development 54.0%) and 71.5% received a drain to treat
hydrocephalus after subarachnoid bleeding, (intraventricular)
hemorrhage or infarction (model development 49.0%) and in-
hospital mortality after exclusion of patients who died within
24 hours of drain placement was 21.9%. The area under the ROC
curve, which is a measure of discrimination, was 0.951 (95%
confidence interval (CI) 0.914 to 0.988); during model develop-
ment an area under the ROC curve of 0.976 (95% CI 0.965–
0.987, without correction for optimism) was observed [14].
Calibration-in-the-large, a measure of the total number of
infections in a specified time period, predicted 13.46 infections
in 2010 (observed = 13 infections) and 6.06 infections between
January 1st and June 10th 2011 (observed = 7). Table 1 gives the
contingency table obtained after application of the original
prediction model and threshold.
Model update
The model was updated to incorporate newly available data and
optimize performance in new patients. The total 2004–2011
dataset included 653 patients which received 863 drains. The
observed infection rate was 14.1/1000 DAR (16.7/1000 DAR for
Table 2. Model update results for 2004–2011 data, including baseline characteristics and results of univariable and multivariable
analysis.
Results of univariable analysis Results of multivariable analysisb
no DRM DRM p-valuea Estimate OR 95% CI
Median (IQR) or n (%) n = 549 n = 104
Baseline characteristics:
Age (years) 59.3 (47.3–69.3) 56.1 (47.4–66.4) 0.599
Sex (% female) 307 (55.9) 58 (55.8) 0.997
In-hospital mortality (%) 105 (19.5) 12 (11.5) 0.064
Duration of admission (days) 19 (11–30) 41 (29–63) ,0.001
ICU admission (%) 322 (58.7) 75 (72.1) 0.010
Predictors in previous model:
Drain Type (% EVD) 352 (64.1) 93 (89.4) ,0.001 1.49 4.421 1.461–13.373
Number of drains placed 1 (1–1) 2 (1–2) ,0.001 0.52 1.687 1.154–2.698
CRP (mg/L)c 99 (37–183) 143 (94–189) ,0.001 20.08 0.926 0.883–0.972
Peripheral leukocytes (6109/L) 15.3 (11.4–19.4) 20.3 (16.4–24.3) ,0.001 0.08 1.090 1.022–1.153
CSF leukocytes (6100/uL)d 1.9 (0.2–6.4) 12.9 (2.7–83.8) ,0.001 0.20 1.224 1.058–1.416
CSF and/or drain culturee (%) 54 (9.8) 77 (74.0) ,0.001
Any empiric antibiotic therapy (%) 72 (13.1) 81 (77.9) ,0.001 1.80 6.067 2.632–13.983
Number of antibiotics started 1 (0–2) 4 (3–6) ,0.001 0.20 1.225 0.988–1.519
New variables considered:
Emergency admission (%) 312 (56.9) 68 (65.4) 0.109
Discharge to ,0.001
– Home 235 (42.8) 25 (24.0)
– Other (deceased, care facility) 314 (57.2) 79 (76.0)
CSF and/or drain culture or Gram staine 59 (10.7) 79 (76.0) ,0.001 2.50 12.117 5.202–28.225
a: p-value in univariable analysis by student’s t test, Mann-Whitney U test or Chi-square where appropriate.
b: Results of the multivariable analysis are after bootstrapping (shrinkage factor 0.79). The intercept of the model was estimated at –6.615.
c: In the multivariable analysis, all CRP values were divided by factor 10.
d: In the multivariable analysis, CSF leukocytes were log transformed.
e: Culture results corrected for contamination with skin flora; if no antibiotics were started, culture was classified as negative.
Abbreviations: CRP – C-reactive protein; CSF – cerebrospinal fluid; DRM – Drain-related meningitis; EVD – external ventricular drain; OR – Odd’s ratio.
doi:10.1371/journal.pone.0051509.t002
Figure 3. Observed and predicted group-level infection rates
using updated model, per 1000 days at risk with 95%
confidence intervals. Abbreviations: DRM – drain-related meningitis,
DAR – days at risk, N pat – number of patients, N DAR – number of days
at risk, N DRM – number of cases of drain-related meningitis.
doi:10.1371/journal.pone.0051509.g003
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EVDs, 6.0/1000 DAR for ELDs). Baseline characteristics and the
results of model re-estimation are presented in Table 2. Patients
who developed DRM received multiple courses of antibiotics
during their surveillance episode; most likely they suffered from or
were suspected of other concomitant infections. The higher
mortality in the non-affected group is in part caused by the
shorter duration of follow-up in the deceased patients; hence they
had less time to develop a DRM.
In the multivariable analysis, using a fractional polynomial to fit
the model to the CRP levels did not lead to the inclusion of higher
power terms in the model and only the linear term was retained,
albeit with a reversed direction. This is most likely because patients
with a very high CRP level suffered from a different infection than
DRM. The area under the ROC curve of the updated model was
0.972 before correction for optimism and 0.963 (95% CI 0.953–
0.974) after correction for over-optimism. Table 3 shows
classification results with varying predicted probability cut-offs.
Finally, yearly infection rates can be estimated by summing
predicted probabilities (calibration-in-the-large) for all patients in
each year group (Figure 3).
Discussion
The results of the present study demonstrate that the previously
proposed model for the surveillance of DRM, in unaltered form,
maintains its high discriminatory power and adequate group-level
prediction in a new patient population from the same center.
Patients included in the validation set were on average more
seriously ill than in the derivation set, probably due to the
discontinuation of surveillance of patients receiving ELDs.
However, this did not impact model performance. Model update
was performed to include predictors that recently became
available and optimize the model. Performance of the updated
model is similar to the original model. As described in Table 3, a
choice needs to be made between sensitivity and specificity in
selecting a predicted probability cut-off; increasing the predicted
probability cut-off reduces the number of charts to review at the
cost of sensitivity. Since this model is applied to patients
retrospectively and does not affect clinical decision making, it is
worthwhile to, accept a sensitivity of 95.2% as opposed to 100.0%
which will reduce the workload for manual review from 223 to 159
charts. As in model development, longitudinal surveillance at the
group level can be performed using this model. Comparison of the
original and revised model regression coefficients yields similar
directions and slightly more conservative magnitudes due to the
more stringent model shrinkage procedure used in the model
update.
The observed rates of DRM in this study are in the upper part
of the spectrum of rates published. The use of a broad definition
that includes infections in which no micro-organisms were
cultured from CSF may play a role (26% of the infections) [10].
Furthermore, as opposed to benchmarking data from Germany
[30], both ICU and non-ICU patients are included in the
surveillance and follow-up is extended beyond ICU discharge. The
lower infection rate observed in patients who received an ELD
(16.7 vs 6.0/1000 DAR) may be explained by the less severe
underlying disease in these patients. Schade et al. also found lower
DRM rates in patients receiving an ELD as compared to an EVD
[31]; as in our population (data not shown), these patients often
received an ELD for the prevention or treatment of CSF leakage.
In other studies, a higher DRM rate was found in patients
receiving ELDs which may be due to the inclusion of almost
exclusively patients with underlying intracranial hemorrhage [15].
The updated model presented in this research is, to our
knowledge, the only model developed to specifically survey the
development of meningitis complicating the use of external CSF
drains that has undergone temporal validation. Compared to other
automated surveillance systems for (procedure-specific) HAI, this
model is one of the few using data from multiple sources in a
multivariable model which weights the individual predictors to
generate a prediction. This is in contrast to the often seen binary
classification algorithms which use fewer data sources and often
require positive cultures for case-finding [9,32,33]. In this model,
positive cultures and antibiotic use are important predictors but no
absolute requirement for the detection of infection, thus making it
possible to identify those infections in which a positive culture was
Table 3. Model classification results with different predicted probability cut-offs.
P(DRM)
cut-off Sensitivity Specificity PPV NPV
Charts to
review
(%) (%) (%) (%) (% of total)
0.025 100.0 62.5 33.5 100.0 310 (47.5)
0.050 100.0 78.3 46.6 100.0 223 (34.2)
0.075 99.0 82.7 52.0 99.8 198 (30.3)
0.010 99.0 85.8 56.9 99.8 181 (27.7)
0.125 99.0 86.7 58.5 99.8 176 (27.0)
0.150 98.1 87.6 60.0 99.6 170 (26.0)
0.175 95.2 89.1 62.3 99.0 159 (24.3)
0.200 93.3 90.0 63.8 98.6 152 (23.3)
0.225 90.4 91.1 65.7 98.0 143 (21.9)
0.250 87.5 91.8 66.9 97.5 136 (20.8)
0.275 83.7 93.4 70.7 96.8 123 (18.8)
0.300 82.7 94.2 72.9 96.6 118 (18.1)
With increasing cut-off, the sensitivity decrease is associated with a decrease in number of charts requiring manual review for confirmation of infection.
Abbreviations: DRM – drain-related meningitis, NPV – negative predictive value, PPV – positive predictive value, P(DRM) – predicted probability for drain-related
meningitis.
doi:10.1371/journal.pone.0051509.t003
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not obtained or for which the patient was not treated with
standard empiric therapy. The study presented here confirms that
this multivariable approach is valid for the surveillance of HAI,
and may possibly be applied to other infections as well. Currently,
use of the model requires extraction of predictor data from the
electronic medical records and subsequent data processing prior to
application of the prediction rule; ongoing developments in
healthcare information technology are expected to facilitate the
widespread implementation of such systems.
Since the number of external drains placed on a yearly basis is
limited, the validation could only be performed on a relatively
small patient population. Therefore, performing multiple imputa-
tion on this set of data required very relaxed settings which may
cause unstable results. However, the model was subsequently
revised and extended using the total population, one of the largest
DRM cohorts to date, to make optimal use of available data and
return the most reliable model possible. Although model update
considered several new variables that have become available in the
data warehouse, not all potential risk factors and diagnostic
markers of DRM could be included. For example, there is no
(field-defined) data on whether the drains were placed during an
emergency procedure, how often drains were manipulated or
whether there was cerebrospinal fluid leakage at the insertion site
[10,11,34]. Markers of meningitis under investigation, such as
procalcitonin and interleukins [35–37], are not routinely deter-
mined and thus not included. Furthermore, since the model is
dependent on clinical practices, such as culture frequency and
antibiotic use policies, the model may need to be adapted when
implemented in new settings. However, the model will not be
affected by differences in occurrence of causal risk factors
assuming that clinical presentation and diagnostic workup remain
unaffected. The effect on model performance of differences that
may affect clinical presentation, such as use of antibiotic coated
catheters, will need to be investigated further. When interpreting
the results of this study, it must be realized that it has been
developed for the purpose of infection surveillance after the fact,
and not for realtime surveillance of infections. Several studies have
attempted to identify parameters which can predict the onset of
DRM, however with inconclusive results [37,38]. The current
model could be used for more timely feedback of infection rates
and may return more consistent results than manual surveillance.
This model for the surveillance of drain-related meningitis has
now been temporally validated in a single center, and maintained
performance despite small changes in case-mix of the validation
set. Multi-center validation is currently ongoing to investigate
transportability to other hospitals and validity in patients with a
different case-mix; also the effect of the use of antibiotic-coated
catheters on model performance will be assessed. Several
challenges still remain to achieve implementation in routine
surveillance. Methods for handling of missing data in future
patients need to be tested, and with the implementation in multiple
centers, risk adjustment methods will be necessary to allow for
valid comparison between centers. Another aspect that will require
attention in the future is quantification of device utilization rates to
generate infection rates with reliable numbers both in the
numerator (this model) and the denominator.
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